blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3201204

EP3201204 - C5-C6-FUSED TRICYCLIC IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.12.2021
Database last updated on 11.05.2024
FormerThe patent has been granted
Status updated on  22.01.2021
FormerGrant of patent is intended
Status updated on  14.09.2020
FormerExamination is in progress
Status updated on  06.03.2019
FormerRequest for examination was made
Status updated on  07.07.2017
FormerThe international publication has been made
Status updated on  21.04.2017
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024 [2024/22]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
[2017/32]
Inventor(s)01 / HE, Shuwen
2000 Galloping Hill Road
Kenilworth, NJ 07033 / US
02 / CUMMING, Jared N.
2000 Galloping Hill Road
Kenilworth, NJ 07033 / US
03 / SCOTT, Jack D.
2000 Galloping Hill Road
Kenilworth, NJ 07033 / US
 [2017/32]
Representative(s)Jaap, David Robert
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2017/32]Jaap, David Robert
Merck Sharp & Dohme Corp.
European Patent Department
Hertford Road
Hoddesdon, Hertfordshire EN11 9BU / GB
Application number, filing date15846682.128.09.2015
[2017/32]
WO2015US52554
Priority number, dateUS201462059631P03.10.2014         Original published format: US 201462059631 P
[2017/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016053828
Date:07.04.2016
Language:EN
[2016/14]
Type: A1 Application with search report 
No.:EP3201204
Date:09.08.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 07.04.2016 takes the place of the publication of the European patent application.
[2017/32]
Type: B1 Patent specification 
No.:EP3201204
Date:24.02.2021
Language:EN
[2021/08]
Search report(s)International search report - published on:US07.04.2016
(Supplementary) European search report - dispatched on:EP13.04.2018
ClassificationIPC:C07D513/14, C07D471/04, C07D519/00, C07D519/06, A61K31/54
[2018/20]
CPC:
C07D417/12 (EP,US); A61K45/06 (US); A61K31/54 (EP,US);
A61K31/549 (EP,US); C07D471/04 (EP,US); C07D513/04 (EP,US);
C07D519/00 (EP,US); C07D519/06 (EP,US) (-)
Former IPC [2017/32]C07D513/14
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/32]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:C5-C6-KONDENSIERTE TRICYCLISCHE IMINOTHIADIAZINDIOXINVERBINDUNGEN ALS BACE-HEMMER, ZUSAMMENSETZUNGEN UND DEREN VERWENDUNG[2017/32]
English:C5-C6-FUSED TRICYCLIC IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE[2017/32]
French:COMPOSÉS DE DIOXYDE D'IMINOTHIADIAZINE TRICYCLIQUES CONDENSÉS EN C5-C6 UTILISÉS COMME INHIBITEURS DE BACE, COMPOSITIONS LES CONTENANT, ET LEUR UTILISATION[2017/32]
Entry into regional phase03.05.2017National basic fee paid 
03.05.2017Search fee paid 
03.05.2017Designation fee(s) paid 
03.05.2017Examination fee paid 
Examination procedure21.04.2017Date on which the examining division has become responsible
03.05.2017Examination requested  [2017/32]
08.11.2018Amendment by applicant (claims and/or description)
14.03.2019Despatch of a communication from the examining division (Time limit: M04)
19.07.2019Reply to a communication from the examining division
17.01.2020Cancellation of oral proceeding that was planned for 12.02.2020
12.02.2020Date of oral proceedings (cancelled)
11.03.2020Despatch of a communication from the examining division (Time limit: M04)
15.07.2020Reply to a communication from the examining division
15.09.2020Communication of intention to grant the patent
18.01.2021Fee for grant paid
18.01.2021Fee for publishing/printing paid
18.01.2021Receipt of the translation of the claim(s)
Opposition(s)25.11.2021No opposition filed within time limit [2022/05]
Fees paidRenewal fee
11.09.2017Renewal fee patent year 03
11.09.2018Renewal fee patent year 04
11.09.2019Renewal fee patent year 05
11.09.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.09.2015
AL24.02.2021
AT24.02.2021
CY24.02.2021
CZ24.02.2021
DK24.02.2021
EE24.02.2021
ES24.02.2021
FI24.02.2021
HR24.02.2021
IT24.02.2021
LT24.02.2021
LV24.02.2021
MC24.02.2021
MK24.02.2021
NL24.02.2021
PL24.02.2021
RO24.02.2021
RS24.02.2021
SE24.02.2021
SI24.02.2021
SK24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
IS24.06.2021
PT24.06.2021
IE28.09.2021
LU28.09.2021
BE30.09.2021
CH30.09.2021
LI30.09.2021
[2024/22]
Former [2023/30]HU28.09.2015
AL24.02.2021
AT24.02.2021
CY24.02.2021
CZ24.02.2021
DK24.02.2021
EE24.02.2021
ES24.02.2021
FI24.02.2021
HR24.02.2021
IT24.02.2021
LT24.02.2021
LV24.02.2021
MC24.02.2021
NL24.02.2021
PL24.02.2021
RO24.02.2021
RS24.02.2021
SE24.02.2021
SI24.02.2021
SK24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
IS24.06.2021
PT24.06.2021
IE28.09.2021
LU28.09.2021
BE30.09.2021
CH30.09.2021
LI30.09.2021
Former [2023/27]HU28.09.2015
AL24.02.2021
AT24.02.2021
CZ24.02.2021
DK24.02.2021
EE24.02.2021
ES24.02.2021
FI24.02.2021
HR24.02.2021
IT24.02.2021
LT24.02.2021
LV24.02.2021
MC24.02.2021
NL24.02.2021
PL24.02.2021
RO24.02.2021
RS24.02.2021
SE24.02.2021
SI24.02.2021
SK24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
IS24.06.2021
PT24.06.2021
IE28.09.2021
LU28.09.2021
BE30.09.2021
CH30.09.2021
LI30.09.2021
Former [2022/37]AL24.02.2021
AT24.02.2021
CZ24.02.2021
DK24.02.2021
EE24.02.2021
ES24.02.2021
FI24.02.2021
HR24.02.2021
IT24.02.2021
LT24.02.2021
LV24.02.2021
MC24.02.2021
NL24.02.2021
PL24.02.2021
RO24.02.2021
RS24.02.2021
SE24.02.2021
SI24.02.2021
SK24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
IS24.06.2021
PT24.06.2021
IE28.09.2021
LU28.09.2021
BE30.09.2021
CH30.09.2021
LI30.09.2021
Former [2022/35]AL24.02.2021
AT24.02.2021
CZ24.02.2021
DK24.02.2021
EE24.02.2021
ES24.02.2021
FI24.02.2021
HR24.02.2021
IT24.02.2021
LT24.02.2021
LV24.02.2021
MC24.02.2021
NL24.02.2021
PL24.02.2021
RO24.02.2021
RS24.02.2021
SE24.02.2021
SI24.02.2021
SK24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
IS24.06.2021
PT24.06.2021
IE28.09.2021
LU28.09.2021
BE30.09.2021
Former [2022/34]AL24.02.2021
AT24.02.2021
CZ24.02.2021
DK24.02.2021
EE24.02.2021
ES24.02.2021
FI24.02.2021
HR24.02.2021
IT24.02.2021
LT24.02.2021
LV24.02.2021
MC24.02.2021
NL24.02.2021
PL24.02.2021
RO24.02.2021
RS24.02.2021
SE24.02.2021
SI24.02.2021
SK24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
IS24.06.2021
PT24.06.2021
LU28.09.2021
BE30.09.2021
Former [2022/25]AL24.02.2021
AT24.02.2021
CZ24.02.2021
DK24.02.2021
EE24.02.2021
ES24.02.2021
FI24.02.2021
HR24.02.2021
IT24.02.2021
LT24.02.2021
LV24.02.2021
MC24.02.2021
NL24.02.2021
PL24.02.2021
RO24.02.2021
RS24.02.2021
SE24.02.2021
SI24.02.2021
SK24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
IS24.06.2021
PT24.06.2021
Former [2022/23]AL24.02.2021
AT24.02.2021
CZ24.02.2021
DK24.02.2021
EE24.02.2021
ES24.02.2021
FI24.02.2021
HR24.02.2021
IT24.02.2021
LT24.02.2021
LV24.02.2021
NL24.02.2021
PL24.02.2021
RO24.02.2021
RS24.02.2021
SE24.02.2021
SI24.02.2021
SK24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
IS24.06.2021
PT24.06.2021
Former [2022/13]AL24.02.2021
AT24.02.2021
CZ24.02.2021
DK24.02.2021
EE24.02.2021
ES24.02.2021
FI24.02.2021
HR24.02.2021
LT24.02.2021
LV24.02.2021
NL24.02.2021
PL24.02.2021
RO24.02.2021
RS24.02.2021
SE24.02.2021
SI24.02.2021
SK24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
PT24.06.2021
Former [2022/10]AL24.02.2021
AT24.02.2021
CZ24.02.2021
DK24.02.2021
EE24.02.2021
ES24.02.2021
FI24.02.2021
HR24.02.2021
LT24.02.2021
LV24.02.2021
NL24.02.2021
PL24.02.2021
RO24.02.2021
RS24.02.2021
SE24.02.2021
SK24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
PT24.06.2021
Former [2022/08]AL24.02.2021
AT24.02.2021
CZ24.02.2021
DK24.02.2021
EE24.02.2021
ES24.02.2021
FI24.02.2021
HR24.02.2021
LT24.02.2021
LV24.02.2021
NL24.02.2021
PL24.02.2021
RO24.02.2021
RS24.02.2021
SE24.02.2021
SK24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
IS24.06.2021
PT24.06.2021
Former [2022/07]AL24.02.2021
AT24.02.2021
CZ24.02.2021
DK24.02.2021
EE24.02.2021
FI24.02.2021
HR24.02.2021
LT24.02.2021
LV24.02.2021
NL24.02.2021
PL24.02.2021
RO24.02.2021
RS24.02.2021
SE24.02.2021
SK24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
IS24.06.2021
PT24.06.2021
Former [2021/50]AT24.02.2021
CZ24.02.2021
DK24.02.2021
EE24.02.2021
FI24.02.2021
HR24.02.2021
LT24.02.2021
LV24.02.2021
NL24.02.2021
PL24.02.2021
RO24.02.2021
RS24.02.2021
SE24.02.2021
SK24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
IS24.06.2021
PT24.06.2021
Former [2021/49]AT24.02.2021
CZ24.02.2021
DK24.02.2021
EE24.02.2021
FI24.02.2021
HR24.02.2021
LT24.02.2021
LV24.02.2021
NL24.02.2021
PL24.02.2021
RS24.02.2021
SE24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
IS24.06.2021
PT24.06.2021
Former [2021/48]AT24.02.2021
CZ24.02.2021
EE24.02.2021
FI24.02.2021
HR24.02.2021
LT24.02.2021
LV24.02.2021
NL24.02.2021
PL24.02.2021
RS24.02.2021
SE24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
IS24.06.2021
PT24.06.2021
Former [2021/46]AT24.02.2021
FI24.02.2021
HR24.02.2021
LT24.02.2021
LV24.02.2021
NL24.02.2021
PL24.02.2021
RS24.02.2021
SE24.02.2021
SM24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
IS24.06.2021
PT24.06.2021
Former [2021/42]FI24.02.2021
HR24.02.2021
LT24.02.2021
LV24.02.2021
NL24.02.2021
PL24.02.2021
RS24.02.2021
SE24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
IS24.06.2021
PT24.06.2021
Former [2021/39]FI24.02.2021
HR24.02.2021
LT24.02.2021
LV24.02.2021
NL24.02.2021
PL24.02.2021
RS24.02.2021
SE24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
PT24.06.2021
Former [2021/38]FI24.02.2021
HR24.02.2021
LT24.02.2021
LV24.02.2021
NL24.02.2021
RS24.02.2021
SE24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
PT24.06.2021
Former [2021/37]FI24.02.2021
HR24.02.2021
LT24.02.2021
LV24.02.2021
RS24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
PT24.06.2021
Former [2021/36]FI24.02.2021
HR24.02.2021
LT24.02.2021
BG24.05.2021
NO24.05.2021
GR25.05.2021
PT24.06.2021
Former [2021/35]FI24.02.2021
HR24.02.2021
LT24.02.2021
NO24.05.2021
PT24.06.2021
Former [2021/33]FI24.02.2021
LT24.02.2021
NO24.05.2021
PT24.06.2021
Documents cited:Search[Y]WO2012162330  (SQUIBB BRISTOL MYERS CO [US], et al) [Y] 1-15 * page 4; claim 1; table 1 *;
 [A]WO2014093190  (MERCK SHARP & DOHME [US], et al) [A] 1-15* claims 1,9-15; table - *;
 [Y]WO2014120658  (AMGEN INC [US]) [Y] 1-15 * page 4, line 14 - line 20; claims 1,27-37; table 2 *
International search[A]WO0037474  (NOVO NORDISK AS [DK]) [A] 1-9* entire document *;
 [A]US2012189642  (SCOTT JACK D [US], et al) [A] 1-9 * entire document *;
 [A]US2014023668  (CUMMING JARED N [US], et al) [A] 1-9 * entire document *;
 [A]WO2014099788  (MERCK SHARP & DOHME [US], et al) [A] 1-9 * entire document *;
 [A]WO2014099794  (MERCK SHARP & DOHME [US], et al) [A] 1-9 * entire document *
by applicantUS2008015180
 WO2010063718
 US2012189642
 US2014023668
 WO2014120658
    - AD. OHNO et al., Neurobiology of Disease, (20070000), vol. 26, pages 134 - 145
    - MCCONLOGUE et al., J. Bio. Chem., (20070000), vol. 282, no. 36
    - AD. ROBERDS et al., Human Mol. Genetics, (20010000), vol. 10, no. 12, pages 1317 - 1324
    - AP. LUO et al., Nature Neuroscience, (20010300), vol. 4, no. 3
    - JONSSON et al., have reported in Nature, (20120800), vol. 488, pages 96 - 99
    - GUO et al., PNAS, (20070814), vol. 104, no. 33
    - GETCHELL et al., Neurobiology of Aging, (20030000), vol. 24, pages 663 - 673
    - BACON AW et al., Ann NY Acad Sci, (20020000), vol. 855, pages 723 - 31
    - CRINO PBMARTIN JAHILL WD et al., Ann Otol Rhinol Laryngol, (19950000), vol. 104, pages 655 - 61
    - DAVIES DC et al., Neurobiol Aging, (19930000), vol. 14, pages 353 - 7
    - DEVANAND DP et al., Am J Psychiatr, (20000000), vol. 157, pages 1399 - 405
    - DOTY RL et al., Brain Res Bull, (19870000), vol. 18, pages 597 - 600
    - FINZI, G. FRANZI et al., Ultrastruct Pathol., (20081100), vol. 32, no. 6, pages 246 - 51
    - LOANE et al., "Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury", Nature Medicine, (20090000), vol. 15, doi:10.1038/nm.1940, pages 377 - 379, XP002556420

DOI:   http://dx.doi.org/10.1038/nm.1940
    - YU et al., "Lithium reduces BACE1 overexpression, β amyloid accumulation, and spatial learning deficits in mice with traumatic brain injury", J Neurotrauma, (20120900), vol. 29, no. 13, doi:10.1089/neu.2012.2449, pages 2342 - 51, XP055365660

DOI:   http://dx.doi.org/10.1089/neu.2012.2449
    - TRAN et al., "Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-P accumulation and independently accelerates the development of tau abnormalities", J Neurosci., (20110629), vol. 31, no. 26, pages 9513 - 25
    - "Pro-drugs as Novel Delivery Systems", T. HIGUCHIW. STELLA, A.C.S. Symposium Series, and in Bioreversible Carriers in Drug Design, American Pharmaceutical Association and Pergamon Press, (19870000), vol. 14
    - S. BERGE et al., Journal of Pharmaceutical Sciences, (19770000), vol. 66, no. 1, pages 1 - 19
    - P. GOULD, International J. of Pharmaceutics, (19860000), vol. 33, pages 201 - 217
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.